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Introduction
The relationship between renal dysfunction and adverse cardiovascular disease outcomes have been well established in patients with coronary artery disease (CAD) [1] and in those with heart failure [2] . Prior studies utilizing serum creatinine, estimates of glomerular filtration rate (eGFR) or blood urea nitrogen (BUN) to investigate the prognostic role of renal dysfunction in cardiovascular disease have found that BUN is more sensitive than creatinine and eGFR in predicting poor clinical outcomes [1, 3, 4] . In fact, BUN has also been demonstrated to be a valid biomarker for disease severity and prognosis in many other conditions such as communityacquired pneumonia [5] , acute pancreatitis [6] and acute intracerebral hemorrhage [7] .
Acute aortic dissection (AAD) is a life-threatening disorder that necessitates immediate management. Previous studies have demonstrated that kidney injury is a risk factor for both short and long term mortality in patients with AAD [8, 9] . However, these studies used serum creatinine as a surrogate marker for renal dysfunction and whether BUN could also provide some prognostic significance in these patients is unknown. Hence, the aim of the present study was to evaluate the relationship between BUN and in hospital mortality in patients admitted with AAD.
Methods

Study population
Herein is retrospectively investigated the medical records of patients with AAD admitted to the First Affiliated Hospital of Wenzhou Medical University between December 2012 and June 2016. The study was reviewed and approved by the ethics committee of the hospital and informed consent was waived due to its retrospective nature.
The diagnosis of AAD was confirmed by multidetector computed tomography scan and the type of AAD was classified in accordance with Stanford University criteria. Patients were included in the present study if they fulfilled the following criteria: (1) the time interval between symptoms onset and hospital admission of ≤ 24 h; (2) receiving surgical or endovascular repair for AAD during hospitalization. Exclusion criteria included: (1) presence of AAD for more than 24 h; (2) diagnosis with Marfan syndrome; (3) prior history of aortic dissection (AD).
Treatment
For patients with confirmed diagnosis of AD, urapidil, sodium nitroprusside or nitroglycerine were was administered intravenously to reduce systolic blood pressure (SBP) to 100-120 mmHg. Beta-blocker was administered to all patients except those with the contraindication.
All type A AD patients and a small part of type B AD patients underwent surgery repair via cardiopulmonary bypass. Endovascular repair was performed using commercially available endografts with the patients under general anesthesia.
Data collection
The following clinical data were collected on admission: age, sex, presence of hypertension, CAD, dyslipidemia, diabetes mellitus (DM), smoking and drinking habits, type of AAD, aortic diameter, blood pressure, heart rate, and laboratory data.
Endpoint
The study endpoint was defined as all-cause mortality during hospitalization.
Statistical analysis
Normality of continuous data was assessed using the Shapiro-Wilk test. Continuous variables are presented as the mean ± standard deviation or median and interquartile range according to whether they follow normal distributions. Categorical variables are presented as proportions. Comparisons between groups were performed with unpaired Student t tests for normally distributed continuous variables and Wilcoxon Mann-Whitney tests for non-normally distributed continuous variables. Categorical variables were compared by c 2 tests or Fisher's exact test when appropriate. Univariate analysis and multiple logistic regression analysis were used to identify the predictors of in-hospital mortality. Receiver operating characteristic (ROC) analysis was performed to determine the cut-off value for BUN in predicting inhospital mortality with high sensitivity and specificity. A p value < 0.05 was considered to be statistically significant. All the statistical analyses were performed using SPSS statistical software, version 19.0 (SPSS Inc., Chicago, Illinois).
Results
Baseline clinical characteristics
Six hundred twenty six patients were identified with a diagnosis of AD, of whom 251 were admitted within 24 h after onset of symptoms. Among them, 8 patients diagnosed with Marfan syndrome, 9 patients with prior history of AD and 42 patients died during hospitalization with conservative treatment were excluded from analysis. A total of 192 patients met our eligibility criteria and were included in the present study. During hospitalization, 19 patients died and 173 patients survived.
Patient characteristics are shown in Table 1 . There were no significant differences in sex, hypertension, CAD, dyslipidemia, DM, smoking, alcohol use, aortic diameter, heart rate and neutrophil counts between the two groups. Compared with survivors, the non-survivors were older (62 [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] 
Predictors for in-hospital mortality
Logistic regression was performed to identify potential predictors for in-hospital mortality in patients with AAD. Variables included in the univariable logistic regression analysis for inhospital mortality were age, type A AD, SBP, DBP, white blood cell counts, hemoglobin, creatinine and BUN. Except for white blood cell counts, all variables included were significantly associated with in-hospital mortality in univariable logistic regression ( Table 2 ). The multivariable logistic regression model for in-hospital mortality included all variables from the univariable analysis. The only variables that remained as independent predictors of in-hospital mortality were age (odds ratio CI -confidence interval; OR -odds ratio; rest abbreviations as in Table 1 www.cardiologyjournal.org p = 0.0037) and BUN (OR 1.415, 95% CI 1.016--1.971, p = 0.040) ( Table 3) . Given the high mortality rates in patients with type A AD and those who undergo surgery treatment, subgroup analysis was performed by the type of AD and treatment. In patients with type A AD, BUN was associated with high risk of in-hospital mortality (OR 1.663, 95% CI 1.006-2.747, p = 0.047). For patients with type B AD, BUN was not an independent predictor for in-hospital mortality. As for the subgroup, stratified by surgical or endovascular repair, BUN independently predicted in-hospital mortality (OR 1.811, 95% CI 1.190-2.756, p = 0.006; OR 1.379, 95% CI 1.023-1.859, p = 0.035, respectively) (Fig. 1) .
ROC analysis
ROC analysis yielded an area under the curve (AUC) statistic of 0.785 (95% CI 0.662-0.909, p < 0.001) and the cut-off value of BUN to predict in-hospital mortality was 6.95 (sensitivity 78.9%, specificity 72.2%) ( Table 4 , Fig. 2 ).
Discussion
The main findings of the present study were that admission BUN levels were independently associated with in-hospital mortality in patients with AAD admitted within 24 h after onset of symptoms. When BUN was ≥ 6.95 mmol/L, the sensitivity and specificity for in-hospital mortality were 78.9% and 72.2%, respectively. CI -confidence interval; OR -odds ratio; rest abbreviations as in Table 1 . Table 4 . Diagnostic value of blood urea nitrogen for in-hospital mortality. Urea is synthesized in liver via protein catabolism and blood urea is freely filtered at the glomerulus and undergoes tubular reabsorption. In the absence of enhanced protein catabolism, such as severe infection and burning, trauma, glucocorticoids therapy or high protein diet, urea levels in blood is determined by the GFR and tubular reabsorption. In the setting of AAD, hemodynamic disturbances lead to activation of the neurohormonal axis, resulting in increased sympathetic nervous system [10] and renin-angiotensin-aldosterone system activity [11] . Increased angiotensin and adrenergic stimulation decrease renal urea excretion via effects on vascular, glomerular, and tubular effects on the kidney. These neurohormonal responses cause renal vasoconstriction, decreases in glomerular ultrafiltration, and increases in proximal tubular sodium and water reabsoption. Consequently, the fluid delivery in the collecting conduct will decrease and urine flow will slow. Because urea reabsorption in the distal tubule is urine flow dependent, the decreased slowing of tubular flow will enhance urea reabsorption [12] . Besides, AAD can cause low cardiac output by forming pericardial effusion or myocardial ischemia secondary to coronary artery involvement. In order to preserve systemic perfusion, arginine vasopressin (AVP) is released as a compensatory mechanism. AVP can rapidly increase urea permeability in the collecting duct through phosphorylation and apical plasmamembrane accumulation of the urea transporter A1 (UT-A1) and subsequently lead to increased reabsorption of urea in the collecting duct [13] . Therefore, increased BUN level could be regarded as a surrogate marker for hemodynamic and neurohormonal alternations in AAD.
The prognostic implication of increased BUN has been evaluated in patients with acute decompensated heart failure (ADHF). Studies have demonstrated that in the setting of ADHF, patients with high admission BUN level had low cumulative survival rate [14, 15] . In addition, Miura et al. [16] have shown that in patients admitted for ADHF, a BUN increase during hospitalization also indicated worse long-term prognosis, independent of renal function. Moreover, increased BUN is also associated with worse prognosis in a wide spectrum of patients with acute coronary syndromes [1, 17] . However, few data are available on the relationship between BUN and clinical outcomes in patients with AAD. The present findings indicate for the first time that in patients with AAD receiving surgical or endovascular repair, high admission BUN levels were associated with high in-hospital mortality. BUN may be a promising marker for risk stratification in patients with AAD.
Limitations of the study
This study has several limitations. First, because of its observational nature, some factors that may have influenced the outcome of AD were unavailable, such as D-dimer and C-reactive protein. Second, this study was carried out in patients receiving surgical or endovascular repair for AAD, excluding those receiving conservative treatment, which could limit results to extrapolate to a wider group of patients. Furthermore, this study was carried out in a single institution and enrolled a relatively small number of patients, which precluded subgroup analysis. A future prospective study with a larger sample size is required to confirm these findings.
Conclusions
In summary, the present study found that elevated BUN levels were an independent predictor of in-hospital mortality in patients with AAD receiving surgical or endovascular repair. Serum BUN may serve as a simple marker to identify high risk patients. 
